Doxazosin Tablet
Product Images NDC 59651-894

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 59651-894). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Table 3 (Doxazosin Fig1)

A comparative data table and bar graph showing symptom score and maximum flow rate changes in three clinical studies of doxazosin treatment. The table lists mean baseline values, mean change, and sample sizes for placebo and doxazosin groups at different doses and study durations. The bar graph depicts maximum flow rate and symptom score differences between placebo, 4 mg, and 8 mg doxazosin groups in Study 2.*

FDA Label Image

Figue 1 (Doxazosin Fig2)

Two line graphs showing clinical study results for Doxazosin tablets. The left graph displays the mean change in total symptom score from baseline over 14 weeks, comparing doxyazosin and placebo groups. The right graph shows the mean increase in maximum urinary flow rate (mL/sec) from baseline over the same period for the same groups. Both graphs include error bars and sample sizes (N=50 Doxazosin, N=47 placebo).*

FDA Label Image

Package Label-principal Display Panel (1 mg (100 Tablet Bottle))

Label for Doxazosin Tablets USP 1 mg oral tablets by Aurobindo Pharma Limited. The label indicates 100 tablets per container, with dosage instructions to refer to prescribing information. It includes storage instructions, manufacturing information from India, and distributor details of Aurobindo Pharma USA, Inc. The label features a red strength indicator (1 mg) and an imprint of a white round tablet marked 'D1'.*

FDA Label Image

Package Label-principal Display Panel (2 mg (100 Tablet Bottle))

Label for Doxazosin Tablets, USP 2 mg oral tablets, containing doxazosin mesylate equivalent to 2 mg doxazosin. The label specifies 100 tablets in the container, distributed by Aurobindo Pharma USA, Inc., made in India. Storage instructions and child-resistant container details are included. The label also includes a barcode and coding area information.*

FDA Label Image

Package Label-principal Display Panel (4 mg (100 Tablet Bottle))

Label for Doxazosin Tablets USP, 4 mg strength, oral tablet dosage form. The label displays the NDC 59651-894-01, a depiction of a single blue round tablet marked '04', and states the package contains 100 tablets. Distributed by Aurobindo Pharma USA, Inc., made in India, with storage and handling instructions included.*

FDA Label Image

Package Label-principal Display Panel (8 mg (100 Tablet Bottle))

Label for Doxazosin Tablets, USP 8 mg, an oral tablet product by Aurobindo Pharma Limited. The label states the NDC number 59651-895-01 and indicates a package size of 100 tablets. It includes storage instructions, dosage caution, manufacturer details, and a barcode on the right side. A small image of a round tablet marked with "D8" is also shown.*

FDA Label Image

Chemical Structure (Doxazosin Str)

Chemical structure of doxazosin mesylate, the active ingredient in Doxazosin tablets. The diagram shows the molecular composition including methoxy groups and the mesylate component represented as CH3SO3H.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.